Repare Therapeutics Inc.
NASDAQ:RPTX
1.32 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 84.717 | 111.268 | 159.521 | 334.427 | 326.184 | 94.797 | 10.731 |
| Short Term Investments
| 68.074 | 112.359 | 184.42 | 7.439 | 7.526 | 0 | 0 |
| Cash and Short Term Investments
| 152.791 | 223.627 | 343.941 | 341.866 | 333.71 | 94.797 | 10.731 |
| Net Receivables
| 1.746 | 15.312 | 4.323 | 3.234 | 6.164 | 3.056 | 1.064 |
| Inventory
| 0 | 0 | -2.805 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 16.612 | 4.749 | 5.715 | 6.314 | 6.678 | 0.719 | 0.253 |
| Total Current Assets
| 171.149 | 243.688 | 353.979 | 351.414 | 346.552 | 98.572 | 12.048 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 4.218 | 7.541 | 9.599 | 13.095 | 8.622 | 3.424 | 1.652 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | -0.212 | -0.208 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0.212 | 0.208 | 0.198 |
| Tax Assets
| 0 | 0 | 0 | 3.62 | 1.412 | 0.132 | 0 |
| Other Non-Current Assets
| 1.139 | 2.672 | 0.497 | 0.586 | 0.5 | 0.567 | 0.027 |
| Total Non-Current Assets
| 5.357 | 10.213 | 10.096 | 17.301 | 10.534 | 4.123 | 1.877 |
| Total Assets
| 176.506 | 253.901 | 364.075 | 368.715 | 357.086 | 102.695 | 13.925 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 3.623 | 2.4 | 0.461 | 2.302 | 2.251 | 2.127 | 1.245 |
| Short Term Debt
| 1.845 | 2.4 | 4.342 | 3.442 | 1.394 | 0.625 | 0 |
| Tax Payables
| 0 | 0 | 1.24 | 0.523 | 0.018 | 0.218 | 0 |
| Deferred Revenue
| 0 | 10.222 | 53.102 | 11.921 | 2.073 | 1.49 | 0 |
| Other Current Liabilities
| 19.819 | 24.057 | 19.474 | 16.901 | 5.278 | 1.276 | 0.66 |
| Total Current Liabilities
| 25.287 | 39.079 | 78.619 | 35.089 | 11.014 | 4.246 | 1.905 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.088 | 1.01 | 6.514 | 11.184 | 6.616 | 0.439 | 2.49 |
| Deferred Revenue Non-Current
| 0 | 1.73 | 2.682 | 39.613 | 55.934 | 8.142 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -2.682 | -39.613 | -55.934 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -3.257 | -5.592 | -3.308 | 135.997 | 31.914 |
| Total Non-Current Liabilities
| 0.088 | 2.74 | 5.939 | 45.205 | 59.242 | 144.578 | 34.404 |
| Total Liabilities
| 25.375 | 41.819 | 84.558 | 80.294 | 70.256 | 148.824 | 36.309 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 135.997 | 31.873 |
| Common Stock
| 486.674 | 483.35 | 482.032 | 480.699 | 384.313 | 0.001 | 0.001 |
| Retained Earnings
| -417.798 | -333.109 | -239.313 | -210.266 | -103.358 | -49.941 | -22.725 |
| Accumulated Other Comprehensive Income/Loss
| 0.054 | 0.028 | -0.428 | -0 | 0 | -135.997 | -0.49 |
| Other Total Stockholders Equity
| 82.201 | 61.813 | 37.226 | 17.988 | 5.875 | 271.994 | -31.383 |
| Total Shareholders Equity
| 151.131 | 212.082 | 279.517 | 288.421 | 286.83 | -46.129 | -22.384 |
| Total Equity
| 151.131 | 212.082 | 279.517 | 288.421 | 286.83 | -46.129 | -22.384 |
| Total Liabilities & Shareholders Equity
| 176.506 | 253.901 | 364.075 | 368.715 | 357.086 | 102.695 | 13.925 |